Received Feb 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
patients received only adjuvant; patients received only adjuvant; This non-serious case was reported by a consumer via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: patients received only adjuvant) and inappropriate dose of vaccine administered (Verbatim: patients received only adjuvant ). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown. Additional Information: GSK Receipt Date: 12-FEB-2025 Reporter stated that 3 doses of Shingrix were given in office without being reconstituted and wanted to know how to get adjuvant for their remaining 3 vials of Shingrix. The 3 patients received only adjuvant of Shingrix, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.